ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.
ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.
复制标题
DOI:
10.3390/ijms21176336
复制
发表时间:
2020-09-01
影响因子:
5.6
通讯作者:
Rebeck GW
中科院分区:
文献类型:
--
作者:
Lanfranco MF;Ng CA;Rebeck GW
Apolipoprotein E (APOE) is the major cholesterol carrier in the brain, affecting various normal cellular processes including neuronal growth, repair and remodeling of membranes, synaptogenesis, clearance and degradation of amyloid β (Aβ) and neuroinflammation. In humans, the APOE gene has three common allelic variants, termed E2, E3, and E4. APOE4 is considered the strongest genetic risk factor for Alzheimer’s disease (AD), whereas APOE2 is neuroprotective. To perform its normal functions, apoE must be secreted and properly lipidated, a process influenced by the structural differences associated with apoE isoforms. Here we highlight the importance of lipidated apoE as well as the APOE-lipidation targeted therapeutic approaches that have the potential to correct or prevent neurodegeneration. Many of these approaches have been validated using diverse cellular and animal models. Overall, there is great potential to improve the lipidated state of apoE with the goal of ameliorating APOE-associated central nervous system impairments.
登录
查看更多内容
影响因子:
4.8
作者:
Chen, Hung-Kai;Ji, Zhong-Sheng;Mahley, Robert W.
通讯作者:
Mahley, Robert W.
影响因子:
4.2
作者:
DeMattos, RB;Brendza, RP;Holtzman, DM
通讯作者:
Holtzman, DM
影响因子:
5.3
作者:
Boehm-Cagan, Anat;Michaelson, Daniel M.
通讯作者:
Michaelson, Daniel M.
影响因子:
4.8
作者:
Chen, Hung-Kai;Liu, Zhaoping;Mahley, Robert W.
通讯作者:
Mahley, Robert W.
DOI:
10.1073/pnas.0812697106
发表时间:
2009-02-10
影响因子:
11.1
作者:
Agosta, Federica;Vossel, Keith A.;Gorno-Tempini, Maria Luisa
通讯作者:
Gorno-Tempini, Maria Luisa